Earnings History Data for Achieve Life Sciences (ACHV) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Achieve Life Sciences
Achieve Life Sciences Inc. is a pharmaceutical company. It develops and commercializes cytisine treatment to help people battling nicotine addiction. The Company's product candidates include Custirsen, Apatorsen and OGX-225. Achieve Life Sciences Inc., formerly known as OncoGenex Pharmaceuticals Inc., is based in Bothell, United States.
Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
13-08-2024 | AH | ACHV | Achieve Life Sciences | 155.00 | -0.25 | -0.22 | 0.00 | Achieve Life Sciences GAAP EPS of -$0.25 misses by $0.01 [8/13/2024 4:07 PM] |
4.38 | 0.02 (0.57%) |
4.31 | -0.05 (-1.03%) |
3.03 - 5.98 | 64,462 | 160,000 | 657 | ||
09-05-2024 | AH | ACHV | Achieve Life Sciences, Inc. | 162.01 | -0.26 | -0.24 | -0.50 | Achieve Life Sciences GAAP EPS of -$0.26 [5/9/2024 4:03 PM] |
4.60 | 0.07 (1.55%) |
4.90 | 0.37 (8.17%) |
3.03 - 10.30 | 146,997 | 110,000 | 416 | ||
28-03-2024 | AH | ACHV | Achieve Life Sciences, Inc. | 98.63 | -0.26 | -0.31 | -0.83 | Achieve Life Sciences GAAP EPS of -$0.26 beats by $0.05 [3/28/2024 4:04 PM] |
4.54 | 0.03 (0.55%) |
4.30 | -0.25 (-5.39%) |
3.03 - 10.30 | 124,509 | 140,000 | 2,293 | ||
09-11-2023 | AH | ACHV | Achieve Life Sciences, Inc. | 87.80 | -0.34 | -0.34 | -1.35 | Achieve Life Sciences GAAP EPS of -$0.34 beats by $0.04 [11/9/2023 4:00 PM] |
4.11 | -0.08 (-1.91%) |
4.19 | 0.0 (0.00%) |
2.01 - 10.30 | 34,984 | 20,000 | 663 | ||
14-08-2023 | AH | ACHV | Achieve Life Sciences, Inc. | 96.88 | -0.43 | -0.41 | -1.08 | Achieve Life Sciences GAAP EPS of -$0.43 misses by $0.01 [8/14/2023 4:01 PM] |
5.14 | -0.21 (-3.93%) |
5.21 | -0.14 (-2.62%) |
2.00 - 10.30 | 36,777 | 40,000 | 5,397 | ||
09-05-2023 | AH | 4:05 PM ET (May 9) |
ACHV | Achieve Life Sciences, Inc. | 156.17 | -0.50 | -0.65 | -0.80 | Achieve Life Sciences GAAP EPS of -$0.50 beats by $0.19 [5/9/2023 5:02 PM] |
9.90 | 1.09 (12.37%) |
8.90 | 0.09 (1.02%) |
2.00 - 10.00 | 412,370 | 110,000 | 1,351 | |
16-03-2023 | AH | 4:05 PM ET (Mar 16) |
ACHV | Achieve Life Sciences, Inc. | 93.42 | -0.83 | -0.90 | -0.76 | Achieve Life Sciences GAAP EPS of -$0.83 beats by $0.06 [3/16/2023 4:18 PM] |
4.37 | -0.07 (-1.58%) |
0.0 | 0.0 (0.00%) |
2.00 - 8.12 | 89,144 | 90,000 | 0 | |
14-11-2022 | AH | 4:05 PM ET (Nov 14) |
ACHV | Achieve Life Sciences, Inc. | 19.85 | -1.35 | -1.10 | -0.71 | Achieve Life Sciences GAAP EPS of -$1.35 misses by $0.23 [11/14/2022 4:36 PM] |
2.33 | 0.13 (5.91%) |
2.32 | 0.12 (5.45%) |
2.00 - 8.61 | 413,362 | 50,000 | 58,796 | |
|
||||||||||||||||||
11-08-2022 | AH | 4:00 PM ET (Aug 11) |
ACHV | Achieve Life Sciences, Inc. | 54.22 | -1.08 | -0.79 | -1.53 | Achieve Life Sciences GAAP EPS of -$1.08 misses by $0.25 [8/11/2022 4:18 PM] |
4.97 | -0.23 (-4.42%) |
5.17 | -0.03 (-0.58%) |
4.78 - 10.09 | 84,070 | 30,000 | 521 | |
12-05-2022 | AH | 4:05 PM ET (May 12) |
ACHV | Achieve Life Sciences, Inc. | 65.09 | -0.80 | -0.82 | -1.30 | Achieve Life Sciences GAAP EPS of -$0.80 in-line [5/12/2022 4:04 PM] |
6.73 | 0.34 (5.27%) |
6.30 | -0.02 (-0.32%) |
5.62 - 10.40 | 42,588 | 60,000 | 6,292 | |
|
||||||||||||||||||
09-11-2021 | AH | 4:05 PM ET (Nov 9) |
ACHV | Achieve Life Sciences, Inc. | 84.69 | -0.71 | -1.09 | -1.14 | Achieve Life Sciences EPS beats by $0.40 [11/9/2021 4:47 PM] |
8.13 | -0.19 (-2.28%) |
8.33 | -0.14 (-1.65%) |
6.63 - 16.10 | 60,595 | 60,000 | 102 | |
13-05-2021 | AH | ACHV | Achieve Life Sciences, Inc. | 60.88 | -1.30 | -0.78 | -2.20 | Achieve Life Sciences EPS misses by $0.27 [5/13/2021 4:35 PM] |
9.33 | 0.33 (3.67%) |
0.0 | 0.0 (0.00%) |
6.80 - 18.26 | 92,611 | 40,000 | 0 | ||
11-03-2021 | AH | ACHV | Achieve Life Sciences, Inc. | 71.62 | -1.11 | -1.27 | 6.00 | Achieve Life Sciences EPS beats by $0.14 [3/11/2021 4:18 PM] |
11.44 | -0.66 (-5.45%) |
11.24 | -0.86 (-7.11%) |
4.51 - 18.26 | 213,427 | 157,196 | 4,260 | ||
12-11-2020 | AH | 4:05 PM ET (Nov 12) |
ACHV | Achieve Life Sciences, Inc. | 30.92 | -1.14 | -1.30 | 9.00 | Achieve Life Sciences EPS beats by $0.17 [11/12/2020 4:06 PM] |
9.73 | 0.69 (7.63%) |
8.95 | -0.09 (-1.00%) |
4.51 - 28.00 | 326,464 | 180,482 | 2,251 | |
|
||||||||||||||||||
06-08-2020 | AH | 4:05 PM ET (Aug 6) |
ACHV | Achieve Life Sciences, Inc. | 21.98 | -1.68 | -3.80 | 10.00 | Achieve Life Sciences EPS beats by $0.79 [8/6/2020 4:32 PM] |
10.93 | -0.77 (-6.58%) |
10.99 | -0.71 (-6.07%) |
4.51 - 50.20 | 656,152 | 2,060,890 | 20,274 | |
|
||||||||||||||||||
14-05-2020 | PM | 8:00 AM ET (May 14) |
ACHV | Achieve Life Sciences, Inc. | 13.48 | -2.20 | 0.00 | -0.88 | Achieve Life Sciences EPS beats by $0.01 [5/14/2020 7:37 AM] |
0.39 | 0.0 (-1.24%) |
0.3710 | -0.02 (-4.87%) |
0.23 - 4.43 | 1,017,191 | 1,049,971 | 4,728 | |
|